96
Participants
Start Date
December 31, 2016
Primary Completion Date
May 11, 2023
Study Completion Date
May 11, 2023
Rasagiline
Rasagiline will be taken for one year at the dose of 1mg a day. and subjects will undergo functional and structural brain imaging to determine if rasagiline is slowing the progression of Parkinson's Disease in the brain.
Placebo
A placebo tablet will be taken for one year, once a day, and at the same dose of 1mg. subjects will undergo functional and structural brain imaging to be compared with the group taking the rasagiline intervention.
Magnetic Resonance Imaging
This test will be performed at baseline and one year.
functional Magnetic Resonance Imaging
This test will be performed at baseline and one year.
Physical Function Performance Test
This test will be performed at baseline and one year.
Laboratory for Rehabilitation Neuroscience, Gainesville
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
University of Florida
OTHER